ArticleFrontiers in oncology2026

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma.

Dan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.